Picture of Kuros Biosciences AG logo

KURN — Kuros Biosciences AG News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Brief: Kuros Biosciences Wins Order For Bone Graft Supply For U.S. Seaspine

Feb 11 (Reuters) - Kuros Biosciences AG  KURN.S :
    * KUROS BIOSCIENCES SIGNS AGREEMENT TO SUPPLY SEASPINE WITH
BONE
GRAFT INCORPORATING KUROS'S ADVANCED SUBMICRON SURFACE
TECHNOLOGY
    * GLOBAL PARTNER TO MARKET AN ADVANCED BONE GRAFT SUPPLIED
BY
KUROS
    * UNDER AGREEMENT KUROS WILL SUPPLY BONE GRAFT IN VARIOUS
FORMS
AND SEASPINE WILL MARKET PRODUCTS UNDER BRAND NAME OSTEOCURRENT
IN U.S. AND OTHER SELECT MARKETS
    * INITIAL SALES IN U.S. ARE EXPECTED PRIOR TO END OF H1
2019.
TERMS OF AGREEMENT WERE NOT DISCLOSED

Further company coverage:  KURN.S 

 (Reporting by Riham Alkousaa)
 ((Riham.Alkousaa@thomsonreuters.com;))

Recent news on Kuros Biosciences AG

See all news